AcquisitionOther
Nuvation Bio Inc. acquired AnHeart Therapeutics
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Nuvation Bio Inc. -> AnHeart Therapeutics · $11.50
The Acquisition, which has been approved by the board of directors of each company and is subject to approval by AnHearts shareholders and other customary closing conditions, will position Nuvation Bio as a late-stage global oncology company with multiple pro
Open source record (SEC) ↗